Get the Stockscreener App
1.9125
2.27%
0.0425
Minerva Neurosciences Inc stock is traded at $1.9125, with a volume of 2,623.
It is up +2.27% in the last 24 hours and up +14.52% over the past month.
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
See More
Previous Close:
$1.87
Open:
$1.89
24h Volume:
2,623
Relative Volume:
0.20
Market Cap:
$13.37M
Revenue:
-
Net Income/Loss:
$-33.65M
P/E Ratio:
-0.4298
EPS:
-4.45
Net Cash Flow:
$-20.83M
1W Performance:
-10.21%
1M Performance:
+14.52%
6M Performance:
-17.21%
1Y Performance:
-36.25%
1-Day Range:
$1.8745
$1.945
1-Week Range:
$1.87
$2.21
52-Week Range:
$1.15
$3.00
Minerva Neurosciences Inc Stock (NERV) Company Profile
Name
Minerva Neurosciences Inc
Sector
Industry
Phone
617-600-7373
Address
1601 TRAPELO ROAD, WALTHAM, MA
Compare NERV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
1.9125 | 13.08M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-08-20 | Reiterated | H.C. Wainwright | Buy |
| May-14-20 | Initiated | BTIG Research | Buy |
| Oct-02-19 | Reiterated | Chardan Capital Markets | Buy |
| Sep-25-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-18-19 | Initiated | William Blair | Outperform |
| May-31-19 | Initiated | H.C. Wainwright | Buy |
| Sep-01-17 | Initiated | Citigroup | Buy |
| Mar-06-17 | Resumed | Jefferies | Buy |
| May-12-16 | Resumed | Jefferies | Buy |
View All
Minerva Neurosciences Inc Stock (NERV) Latest News
What is the risk reward ratio of investing in Minerva Neurosciences Inc. stockMarket Forecast Updates That Work - jammulinksnews.com
Should I hold or sell Minerva Neurosciences Inc. stock in 2025Beginner Investor Planner With Proven Results - jammulinksnews.com
How Minerva Neurosciences Inc. stock performs during market volatilityFree Weekly Return Pick Forecast Reports - Newser
Using economic indicators to assess Minerva Neurosciences Inc. potentialEntry Optimization Guide with Volume Analysis - Newser
Is Minerva Neurosciences Inc. stock reversal real or fakeFree AI Trading Suggestions With Accuracy Focus - Newser
Is it the right time to buy Minerva Neurosciences Inc. stockMarket Forecast Opportunities For Every Investor - jammulinksnews.com
What is Minerva Neurosciences Inc. company’s growth strategyPost Market Opportunities With High Returns - jammulinksnews.com
How moving averages guide Minerva Neurosciences Inc. tradingPredictable Entry Strategy With Technical Backing - Newser
What makes Credicorp Ltd. stock price move sharplySteady Return Plan Based on Data Analysis - Newser
P 500Trade Flow Monitor with Volume Tracker - Newser
Minerva Neurosciences Inc. Tests 50 Day MA After Sharp DeclineAI Driven Buy Alert Trade Blueprint Released - metal.it
Will Minerva Neurosciences Inc. outperform the marketTechnical Setup and Return Forecast Engine - Newser
Published on: 2025-07-29 20:40:52 - metal.it
Is Minerva Neurosciences Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Can Minerva Neurosciences Inc. Rally Enough to Break EvenReliable Alerts for Daily Stock Movers Released - metal.it
Will JFBR stock benefit from interest rate changesHigh Return Idea With Technical Filter - Newser
Published on: 2025-07-28 20:31:01 - metal.it
Published on: 2025-07-28 00:43:48 - jammulinksnews.com
Minerva Neurosciences Inc. Flashes Rebound Signal in Oversold ConditionOptimized Watchlist With Daily Adjustments Launched - metal.it
Published on: 2025-07-28 16:14:36 - metal.it
What is the dividend policy of Minerva Neurosciences Inc. stockAccelerated capital growth - jammulinksnews.com
What are analysts’ price targets for Minerva Neurosciences Inc. in the next 12 monthsBuild wealth faster with consistent investment plans - jammulinksnews.com
What catalysts could drive Minerva Neurosciences Inc. stock higher in 2025Achieve breakthrough profits with smart strategies - jammulinksnews.com
What are the latest earnings results for Minerva Neurosciences Inc.Capitalize on fast-moving trading opportunities - jammulinksnews.com
How many analysts rate Minerva Neurosciences Inc. as a “Buy”Achieve fast wealth growth with smart picks - jammulinksnews.com
NLY.PRF Company Revenue and Profit Trends: A Deep DiveMassive Upside Selection - Newser
Why Fangdd Network Group Ltd. stock attracts strong analyst attentionFree Growth Investment Group - Newser
How does Minerva Neurosciences Inc. generate profit in a changing economyTriple-digit growth rates - jammulinksnews.com
What analysts say about SNV.PRE stock outlookReal Time Alert Service - Newser
Intrinsic Value of LPRO Stock: Is It Undervalued or OvervaluedEarly Buy Suggestion - Newser
Why Hanesbrands Inc. stock is on top investor watchlistsSteady Profit Stock Forecasts - Newser
CXAI Stock Performance After Earnings: Historical InsightsDefensive Stock Picks with Upside - Newser
Is it the right time to buy LGVN stockExceptional gains - jammulinksnews.com
Is Minerva Neurosciences Inc. a good long term investmentFree Stock Selection - PrintWeekIndia
BRP Inc. Stock Analysis and ForecastGame-changing returns - PrintWeekIndia
What drives Rentokil Initial plc Depositary Receipt stock priceFree Investment Timing Strategies - PrintWeekIndia
What institutions are buying IDYA stock nowHigh-profit trading signals - jammulinksnews.com
Minerva Neurosciences Inc. Stock Analysis and ForecastRecord-breaking gains - Autocar Professional
What drives Minerva Neurosciences Inc. stock priceFree Predictions - Autocar Professional
What makes Minerva Neurosciences Inc. stock price move sharplyFree Join Group - Newser
What analysts say about ATH.PRA stockTriple-digit returns - Autocar Professional
Best Mid Cap Growth Stocks in India Professional Trading GuidanceRecord-breaking capital gains - Autocar Professional
Blue Coast Hotels Limited (531495) vs yyyMassive stock growth - Autocar Professional
What analysts say about Minerva Neurosciences Inc. stockMarket-leading capital gains - Autocar Professional
Top Long Term Growth Stocks in India Expert Portfolio TipsFree Stock Market Real-Time Monitoring - Autocar Professional
Minerva Neurosciences Inc Stock (NERV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):